Cite
HARVARD Citation
Mikhailova, E. et al. (2022). Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children. British journal of haematology. pp. e6-e9. [Online].